Maravai Lifesciences Holdings MRVI Cash Flow Statement (2020-2026)

NASDAQ MRVI
$7.65 +0.02 (+0.26%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Maravai Lifesciences Holdings Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Maravai Lifesciences Holdings reported cash from operations of $3.99M and free cash flow of $3.62M for the quarter ended Jun 2026, up 138.9% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M-63.02M-6.38M-21.63M
Depreciation and DepletionDep. & Depletion
1.80M1.75M1.85M1.89M1.86M2.00M2.08M2.81M4.07M3.93M4.79M5.56M5.04M5.51M5.69M5.96M5.97M5.97M4.90M5.31M
Share-based CompensationStock Comp.
3.57M2.23M3.63M4.31M4.74M6.00M5.99M9.27M9.99M9.34M12.06M13.76M13.05M10.54M10.40M6.79M9.06M3.93M6.74M10.21M
Deferred Taxes
11.23M17.47M13.22M12.86M9.23M7.01M-1.52M-2.76M-5.53M764.75M0.01M
Gains from Sales and DivestituresGains Divest
11.25M
Asset Writedowns and ImpairmentWritedown
154.24M11.91M12.44M30.45M41.71M0.60M-0.14M
Cash from OperationsCash from Ops.
105.56M58.74M162.30M164.28M110.06M99.33M85.07M19.19M14.17M7.79M-8.47M17.43M13.14M-14.64M-9.39M-10.27M-15.15M-22.77M8.66M3.99M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
4.60M3.65M5.53M6.25M6.25M6.24M6.76M6.85M6.87M6.87M6.87M6.87M6.89M6.90M7.03M7.20M7.21M6.51M6.47M6.47M
Depreciation & Amortization (CF)Dep. & Amort.
1.80M1.75M1.85M1.89M1.86M2.00M2.08M2.81M4.07M3.93M4.79M5.56M5.04M5.51M5.69M5.96M5.97M5.97M4.90M5.31M
Change in Working Capital
Change in ReceivablesChange Receivables
-17.62M51.54M2.22M0.12M-5.83M25.77M-82.41M-7.56M-3.21M8.79M-17.88M-1.89M-6.02M11.43M-10.16M-0.50M-5.12M2.96M7.91M-2.29M
Change in InventoryChange Inventory
8.56M-5.48M-1.20M8.70M2.31M-19.27M3.38M-7.71M1.50M2.18M-0.82M-0.70M1.60M-0.45M-0.45M-3.11M-1.35M-3.09M-0.03M0.77M
Change in Account PayablesChange Payables
-2.62M-0.87M1.95M4.36M-4.42M-3.47M-0.23M1.87M1.99M1.66M-3.68M4.57M-2.42M2.25M-0.71M1.78M-2.91M-5.51M6.16M-1.80M
Change in Accured ExpensesChange Accured Exp.
1.62M7.47M-4.06M2.29M15.89M-5.61M24.23M-17.64M2.38M6.40M-24.12M3.00M-1.06M-1.56M1.84M4.80M2.25M-13.51M-5.34M1.81M
Other Working Capital ChangesOther WC Changes
-42.78M-56.51M-6.52M16.57M26.32M-0.47M23.01M-36.27M-1.08M-1.64M-1.15M-3.70M-0.30M-1.15M-8.49M-6.19M-2.06M-1.89M-1.43M-0.46M
Investing Activities
Capital ExpendituresCapex
1.33M5.66M2.75M1.66M6.47M6.21M7.87M25.06M15.83M16.80M5.67M9.55M8.59M5.85M4.50M2.87M3.66M2.11M4.44M0.37M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in IntangiblesChange Intangibless
0.50M
Acquisitions
238.84M0.13M69.73M-0.11M18.63M0.36M
Cash from Investing ActivitiesCash from Investing
118.63M-5.66M-241.58M-1.66M-5.85M-18.52M-69.73M-24.16M-15.52M-12.90M-4.24M-6.18M-8.96M-4.93M-23.13M-3.24M-2.93M-2.11M-4.44M-0.37M
Financing Activities
Other financing activitiesOther financing
50.09M47.15M39.89M42.59M36.81M30.92M8.30M1.30M-3.44M2.38M2.34M2.35M2.23M-3.54M4.54M0.37M-7.02M-3.87M7.44M
Cash from Financing ActivitiesCash from Financing
-51.28M-49.58M-40.52M-43.41M-37.44M-66.12M-19.21M-43.13M0.78M0.47M-0.56M0.23M0.81M-236.19M-4.90M-1.53M-8.25M-1.82M-55.23M-98.98M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
0.31M0.38M0.73M0.54M0.73M0.36M0.31M
Additional items
Exchange Rate EffectFX Effect
0.03M-0.13M0.07M-0.11M-0.01M0.01M0.03M0.02M
Change in Cash
172.94M3.37M-119.80M119.21M66.77M14.69M-3.87M-48.10M-0.57M-4.64M-13.27M11.48M4.99M-255.76M-37.35M-15.15M-26.33M-26.68M-50.97M-95.34M
Free Cash FlowFCF
104.23M53.09M159.56M162.62M103.59M93.12M77.21M-5.87M-1.66M-9.01M-14.13M7.88M4.54M-20.49M-13.89M-13.14M-18.81M-24.88M4.23M3.62M
Net Cash FlowNCF
172.91M3.51M-119.80M119.21M66.77M14.69M-3.87M-48.10M-0.57M-4.64M-13.27M11.48M4.99M-255.76M-37.42M-15.04M-26.32M-26.70M-51.00M-95.36M

Maravai Lifesciences Holdings Cash Flow Statement API

Pull Maravai Lifesciences Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MRVI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY